Atlas Trials

Efficacy and Safety of Liraglutide in the Treatment of Obesity Combined With Metabolism Associated Fatty Liver Disease

Clinical trial NCT06501326 · UNKNOWN

Trial details

NCT number
NCT06501326
Sponsor
Affiliated Hospital of Nantong University
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Non-alcoholic Fatty Liver DiseaseObesity
Start date
2023-11-01
Primary completion
2024-10-31
Enrollment
102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.